Compound ID | 522
Synonym(s): MC 207110
Class: Efflux pump inhibitor
Details of activity: | Permeates bacteria to other antibiotic compounds; effective on MDR pumps |
Combined with other compounds: | Needs to be coupled with another antibiotic compound |
Institute where first reported: | Microcide Pharmaceuticals; (Essential Therapeutics (Ceased)); Daiichi Sankyo Pharmaceutical, Japan; Essential Therapeutics (Ceased) |
Year first mentioned: | 2000 |
Highest developmental phase: | Preclinical |
Development status: | Experimental |
Reason Dropped: | Essential Therapeutics closed down in 2004 |
Chemical structure(s): | |||||||||||
|
|
External links: | |
PubChem link: | https://pubchem.ncbi.nlm.nih.gov/compound/90665180 |
Citation: |